Nobio

Company Overview

Snapshot

Founded in July 2015 by Ervin Weiss, Nobio operates with 11–50 employees. The company has secured $4M in total capital across 4 funding rounds from 2 investors. In September 2021, Nobio's infinix™ Antibacterial Composites were recognized with a 2021 Best of Class Technology Award.

Business overview

Nobio develops long-term antibacterial and antiviral solutions for medical, dental, and consumer products. The company's core technology utilizes potent particles embedded with highly active antimicrobial molecules that kill a wide range of microorganisms on contact. These particles can be permanently integrated into products or used as coatings, providing bioprotection. Nobio commercializes its technology through its own products, such as the Infinix line for dental fillings, and through partnerships with industry leaders, serving the medical, dental, and consumer product markets.

Strategic signal

In September 2021, Nobio's infinix™ Antibacterial Composites received a 2021 Best of Class Technology Award. This recognition validates the efficacy and market readiness of Nobio's antimicrobial technology in the dental sector, signaling strong potential for broader adoption and strategic partnerships in other medical and consumer product applications.

Company Intelligence Q&A

What is Nobio's core technology?

Nobio's core technology involves potent particles embedded with a high concentration of active antimicrobial molecules that effectively kill a wide range of microorganisms, including bacteria, viruses, and fungi, on contact. These particles can be permanently integrated into products or applied as coatings.

When did Nobio receive FDA clearance for its antibacterial composites?

In September 2020, Nobio's antibacterial composites received FDA 510(k) clearance for addressing a key process in tooth decay.

Which of Nobio's products received a Best of Class Technology Award?

Nobio's infinix™ Antibacterial Composites were recognized as a 2021 Best of Class Technology Award winner in September 2021.

Did Nobio receive any grants for its work on protective measures against COVID-19?

Yes, in April 2020, Nobio secured a grant from the Israel Innovation Authority for its work on protective measures against COVID-19.

When did Nobio receive FDA approval for its antibacterial dental fillings?

In August 2019, Nobio received FDA approval to market Infinix, its line of antibacterial products for dental fillings.